Background/Aims: Recent studies have indicated that exosomes play an important role in adipose-derived stem cell (ADSC) transplant-mediated ischaemic heart disease therapy. However, the treatment effect is not obvious. The aim of this study is to investigate whether ADSC-derived exosomes enriched with microRNA (miR)-126 have a more protective effect on acute myocardial infarction (AMI). Methods: Exosomes were characterized by transmission electron microscopy, and the exosome particles were further examined using nanoparticle tracking analyses. A rat model of myocardial infarction and in vitro model of hypoxia-induced H9c2 myocardial cell injury were established to study the protective mechanism of exosomes from miR-126-overexpressing ADSCs. Results: The in vitro results showed that exosomes derived from miR-126-overexpressing ADSCs decreased H9c2 myocardial cell injury by hypoxic conditions. Matrigel ® and Transwell ® assays showed that miR-126-enriched exosomes In vivo studies enriched exosomes. However, blood vessel formation was promoted in the infarction region of AMI rats. Conclusions: The results suggested that the expression of miR-126-enhanced ADSC-derived exosomes prevented myocardial damage by protecting myocardial cells from
Introduction
Acute myocardial infarction (AMI) is a leading cause of death worldwide [1, 2] . Recent studies have found that stem cell transplantation is useful for treating myocardial infarction [3] . Many groups have used adipose-derived stem cells (ADSCs) because they are abundant, lack donor limitations, and present a low risk of side effects. After lineagenumerous cytokines and growth factors that confer reparative capabilities after stem cell mobilization or transplantation. In addition to these advantages, many studies have used ADSCs for cell therapies and tissue engineering due to their ease of obtainment and ischaemic microenvironment of acute myocardial infarction [4, 5] . To increase the survival of the transplanted cells, genetically engineered methods have been used [6, 7] , but ethical and safety challenges remain.
Therefore, further studies are necessary to improve the microenvironment of myocardial infarction and enhance the effects of stem cells under safer conditions. Exosomes (30-to 100-nm small membrane vesicles) derived from ADSCs have been used to treat AMI [7, 8] . Exosome-mediated cell-cell microcommunication through inherent molecules such as nucleotides, proteins, and bioactive lipids has been reported [9] [10] [11] . Exosomes play an important role as key transporters of paracrine factors in angiogenesis, immune regulation, and tissue regeneration [12] [13] [14] . However, the contribution of exosomes to the cardiac microenvironment after acute myocardial infarction still needs further understanding.
MicroRNAs (miRNAs) are small, endogenous, noncoding RNAs that post-transcriptionally regulate gene expression. They play a critical role in proliferation, differentiation, apoptosis, and the stress response. Recently, several reports have suggested that miRNAs suppressed the myocardial damage after AMI by improving the myocardial tissue microenvironment [15] [16] [17] .
Recently, studies have shown that miR-126 plays an important role in improving myocardial damage after AMI [18, 19] . To further study this effect, we used ADSC-derived exosomes with increased levels of miR-126. The therapeutic effects of exosomes on AMI were investigated by treating the cells or AMI rats with miR-126-overexpressing ADSCderived exosomes. The results showed that miR-126-enriched exosomes have a better therapeutic effect by reprogramming the microenvironment of acute myocardial infarction, thus promoting improved heart function after an ischaemic injury.
Materials and Methods

Reagents
and GAPDH were purchased from Sigma-Aldrich (St. Louis, MO, USA). The miR-126 mimics were from endothelial basal medium, and foetal bovine serum (FBS) were from Nego (Shanghai, China). Cell lysis buffer (10×) was obtained from Cell Signaling Technology (Danvers, MA, USA). A real-time PCR (RT-PCR) kit was purchased from Toyobo (Shanghai, China). Other reagents included 4',6-diamidino-2-phenylindole PCR primers were synthesized by Shenggong Biotechnology (Shanghai, China). All chemicals and reagents were of analytical grade.
Ethical statement
All animals were treated in accordance with the Guide for the Care and Use of Laboratory Animals, and all experiments were approved and performed according to the guidelines of the Ethics Committee of Pudong New Area Gongli Hospital, Shanghai, China. All surgical procedures were performed under anaesthesia, and every effort was made to minimize suffering. Rats were anaesthetized by intraperitoneal injection of pentobarbital sodium (30 mg/kg). The isolation and culture of ADSCs were conducted as previously described [20] Dawley rats (80-120 g) were euthanized, and adipose tissue was obtained from the inguinal depots and washed with phosphate-buffered saline (PBS) to remove any residual blood. The tissues were cut into 1 × 1 mm sized pieces and digested with collagenase I. After centrifugation at 4, 000 g for 5 min, the cell pellet was resuspended in DMEM containing 10% FBS/1% penicillin-streptomycin/2 mM L-glutamine and was 2 at 37 °C for 48 h. The medium containing non-adherent cells was then removed, and fresh culture medium was added. The medium was changed every 3 days. Cells the identity of the cells, we incubated ADSCs with conjugated monoclonal antibodies against CD29, CD90, CD45, CD105, or CD34. Isotype-identical antibodies served as controls (Pharmingen, San Diego, CA, USA). For the analyses of CD29, CD90, CD45, CD105, and CD34, cells were further incubated with a biotinylated horse anti-mouse IgG (H1L) antibody and FITC-conjugated streptavidin (Caltag, South San Francisco, CA, using a FACSCalibur ™ sample.
Culture media from both ADSC cells and miR-126-overexpressing ADSCs cells (miR-126-ADSCs) (miR-126 mimics or miR-126 NC (GenePharma, China) were transfected into ADSCs cells using Lipofectamine 2000 (Invitrogen, CA, USA) according to the manufacturer's instructions. At 48 h after transfection, cells were harvested for RT-PCR analyses) were collected and centrifuged at 3000 × g for 15 min to remove cells and cell debris. The supernatant was further concentrated by centrifugation for 30 min at 5000 × g ™ reagent (System Biosciences, Palo Alto, CA, USA) by vortexing, further incubated overnight, and then centrifuged at 1, 500 × g for 30 min at 4 °C to obtain the pellet. The pellet was on a NanoSight LM10 (Malvern Instruments Ltd, Malvern, UK) was performed and analysed using NTA 3.0 software (Malvern).
The protein levels of CD63, CD9, and TSG101 (representative markers of exosomes) were detected by western blotting. The concentration of the exosome proteins was assessed using the Bicinchoninic Acid Assay Kit (Beyotime, Suzhou, China). The ultrastructure of the exosomes was analysed using the Libra 120 transmission electron microscope (Zeiss, Oberkochen, Germany)
Exosome labelling and uptake added to the exosome suspension and incubated for 5 min at room temperature. The reaction was then stopped by adding an equal volume of exosome-depleted bovine serum albumin, and the exosomes were washed twice with PBS to remove any unbound dye. Subsequently, the Dil-labelled or denatured exosomes obtained using a confocal microscope.
The cardiomyoblast cell line H9c2 was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in DMEM supplemented with 10% FBS. To identify the protective effect of exosomes secreted from ADSCs on myocardial, co-culturing of ADSCs and H9c2 was performed using the Transwell ® contact. The H9c2 cells were cultured in the lower wells and grown for an appropriate period. The ADSCs were then placed in the upper wells. To mimic hypoxia injury , cells were cultured in a hypoxia incubator chamber (93% N 2 , 2% O 2 and 5% CO 2 ) for 24 h. To analyse the effects of the exosomes secreted from ADSCs on hypoxic-induced H9c2 cell damage, GW4869 (Sigma-Aldrich) was added to the cultures at a H9c2 cells were harvested for biological analyses. , 2% O 2 , and 93% N 2 Hypoxia + exosomes group and Hypoxia + miR-126-exosomes group, H9C2 cells were cultured under the same conditions, and the ADSC exosomes were added at 200 µg/mL. Twelve hours later, the images were basal medium) was regarded as a measure of angiogenesis. Male Sprague-Dawley rats weighing 220-250 g were used for myocardial infarction studies. Myocardial infarction was produced by surgical ligation of the left anterior descending coronary artery (LAD). After being anaesthetized by intraperitoneal injection of sodium pentobarbital (30 mg/kg), the chest was opened at the left fourth intercostal space, and the LAD was ligated by a 6-0 silk suture 1 mm below the tip of the the ligation operation. Animals were then followed for one additional month and then euthanized. Cardiac muscle tissues were collected for histochemical analyses.
deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling (TUNEL) using a commercially
The microvessel density of the infarction regions was measured by von Willebrand Factor (vWF) staining.
Western blotting
with primary antibodies followed by secondary antibodies. Horseradish peroxidase-labelled secondary antibodies were detected using chemiluminescence, and the greyscale image of the protein bands was analysed using Gel-pro Image Analysis Software (Media Cybernetics, Rockville, MD, USA). The data are expressed as the means ± standard deviation (SD) from at least three independent experiments and were analysed using one-way ANOVA and Tukey's post hoc test. In all cases, P
Results
exosomes
Isolated ADSCs were labelled with different cell surface markers to determine the cell phenotypes. ADSCs were positive for the MSC markers CD29, CD90, CD44, and CD105 and negative for the endothelial markers CD34 and vWF, as previously reported (Fig. 1) [20]. ™ reagent were 50-100 nm in diameter, as determined by transmission electron microscopy (Fig.  2a) . Most exosomes were membrane vesicles. CD63, a representative marker -tometry (Fig. 2b) . These data demonstrated that ADSC-derived exosomes of the ADSC-derived exosomes, we performed size analyses using the nanoparticle tracking system, revealing a peak size of 83.8 nm (Fig. 2b) . The expression of the exosome markers CD9, CD63, and -ern blotting (Fig. 2c) .
RT-PCR analysis showed that after transfection with miR-126 mimics for 48 h, the expression of miR-126 in exosomes derived from ADSCs was increased compared with that in the control group (Fig. 3a) . To determine whether exosomes could be transferred in a paracrine manner, we employed a Transwell ® coculture system for ADSCs and H9c2 cells in which the contact or the transfer of larger vesicles (Fig. 3b) . ADSC cells were transfected with pCT-CD63-more obvious after 24 h of coculture (Fig. 3c) . These results showed that exosomes could be transferred between ADSCs and H9c2 cells during coculture.
To verify whether exosomes from miR-126-overexpressing ADSCs could have better protective effects against hypoxia-induced myocardial cell injury, we measured the cell viability of H9c2 cells using a CCK8 kit after coculture with ADSCs under hypoxic conditions viability of H9c2 cells was suppressed after hypoxia treatment. Coculture increased the cell viability, especially coculture with miR-126-overexpressing ADSCs. However, the protective effects were decreased after pretreatment with the exosome inhibitor GW4869. The results suggested that the protective effects of ADSCs against hypoxia-induced myocardial cell injury were mediated by exosomes (Fig. 3d) .
lower in the miR-126-overexpressing ADSC-treated H9c2 cells under hypoxic conditions than in the ADSC-treated H9c2 cells. Inhibition of exosome release decreased the protective effect of ADSCs on H9c2 cells with hypoxia induction (Fig. 3e and f) . cells were detected by ELISA. The results showed that exosome release from miR-126-greater than the effect with ADSC exosomes. The inhibition of exosome release from ADSCs cells after exposure to hypoxia (Fig.  related protein expression as determined by western blot analyses (Fig. 3j-3n ).
Myocardial repair and the improvement of cardiac systolic function may be related to the promotion of angiogenesis.
studies have shown that tube-like structures are < 0.05). Exosomes derived from the miR-126-overexpressing ADSCs had better promoting effects than those from the other cell groups under hypoxic conditions ( Fig. 4a and 4b ).
than that in the PBS-treated group (P < 0.05) after incubation under hypoxic conditions for 16 h before pretreatment with the exosomes for 24 h. The results also showed that exosomes rat model. Exosomes from miR-126-overexpressing ADSC prevented cardiomyocyte apoptosis and promoted cell proliferation in the border zone. Furthermore, the exosomes promoted myocardial repair, which was also related to the promotion of angiogenesis and It is well known that the exosome contains mRNA, DNA, miRNAs, and proteins. The proteins and/or miRNAs carried by ADSC exosomes may be associated with the promotion of cell protection and angiogenesis. It has been reported that exosomes from ADSCs have therapeutic effects in many diseases, including AMI [22-27]. 
Conclusion
In summary, the results demonstrated that exosomes from autologous ADSCs may provide a promising and safe treatment strategy for AMI therapy. When transfected with miR-126, the ADSCs had increased therapeutic effects.
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